T1 (N=29) | T2 (N=29) | T1 | T2 | ROC analysis | ||||||
---|---|---|---|---|---|---|---|---|---|---|
Group 1 (N=14) | Group 2 (N=15) | p | Group 1 (N=14) | Group 2 (N=15) | p | T1 AUC (95% CI) | T2 AUC (95% CI) | |||
Hemoglobin (mmol/l) | 7.8 ± 0.6 | 5.4 ± 0.5 | 7.7 ± 0.5 | 7.8 ± 0.8 | 0.435 | 5.6 ± 0.5 | 5.3 ± 0.4 | 0.098 | 0.377 (0.165-0.590) | 0.714 (0.517-0.912) |
Hematocrit (%) | 37.2 ± 3.3 | 25.9 ± 2.3 | 36.8 ± 2.6 | 37.7 ± 3.8 | 0.475 | 26.8 ± 2.2 | 25.1 ± 2.2 | 0.044 | 0.401 (0.186-0.617) | 0.732 (0.540-0.924) |
Platelet number (*109/l) | 215 ± 61 | 128 ± 42 | 249 ± 57 | 184 ± 48 | 0.002 | 152 ± 40 | 105 ± 31 | 0.002 | 0.834 (0.690-0.979) | 0.857 (0.705-1.009) |
Fibrinogen (g/l) | 2.9 ± 0.7 | 1.7 ± 0.4 | 3.1 ± 0.8 | 2.7 ± 0.5 | 0.198 | 1.9 ± 0.5 | 1.5 ± 0.3 | 0.045 | 0.627 (0.419-0.835) | 0.703 (0.512-0.894) |
D-dimers (ng/ml) | 700 ± 782 | 1109 ± 1146 | 949 ± 1063 | 467 ± 235 | 0.119 | 1083 ± 1069 | 1132 ± 1251 | 0.909 | 0.654 (0.442-0.866) | 0.547 (0.333-0.761) |
Antithrombin (%) | 80.9 ± 11.5 | 49.6 ± 6.6 | 80.1 ± 7.8 | 81.6 ± 14.4 | 0.727 | 50.1 ± 7.1 | 49.0 ± 6.3 | 0.651 | 0.440 (0.229-0.651) | 0.574 (0.364-0.783) |
PT (sec) | 11.5 ± 0.5 | 15.4 ± 1.5 | 11.4 ± 0.6 | 11.5 ± 0.4 | 0.417 | 15.2 ± 1.3 | 15.7 ± 1.6 | 0.341 | 0.425 (0.205-0.646) | 0.373 (0.168-0.577) |
aPTT (sec) | 28.9 ± 3.2 | 34.6 ± 5.5 | 28.9 ± 3.9 | 28.8 ± 2.7 | 0.922 | 34.1 ± 5.6 | 35.1 ± 5.5 | 0.634 | 0.498 (0.276-0.719) | 0.406 (0.197-0.615) |
ACT (sec) | 132 ± 15 | 140 ± 17 | 134 ± 18 | 131 ± 12 | 0.625 | 140 ± 15 | 141 ± 19 | 0.875 | 0.498 (0.281-0.714) | 0.487 (0.275-0.698) |